Cargando…
Relapse of immune thrombocytopenia after receiving AstraZeneca coronavirus disease‐2019 vaccine: A case report
Immune thrombocytopenic purpura (ITP) is an autoimmune disease characterized by a low platelets count. In this paper, we present a case of ITP relapse in a 31‐year‐old Iranian woman as a potential complication of the AstraZeneca vaccine.
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477723/ https://www.ncbi.nlm.nih.gov/pubmed/37675411 http://dx.doi.org/10.1002/ccr3.7872 |
_version_ | 1785101196354125824 |
---|---|
author | Seyedi, Saba Navid, Shadan Saadatian, Zahra |
author_facet | Seyedi, Saba Navid, Shadan Saadatian, Zahra |
author_sort | Seyedi, Saba |
collection | PubMed |
description | Immune thrombocytopenic purpura (ITP) is an autoimmune disease characterized by a low platelets count. In this paper, we present a case of ITP relapse in a 31‐year‐old Iranian woman as a potential complication of the AstraZeneca vaccine. |
format | Online Article Text |
id | pubmed-10477723 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104777232023-09-06 Relapse of immune thrombocytopenia after receiving AstraZeneca coronavirus disease‐2019 vaccine: A case report Seyedi, Saba Navid, Shadan Saadatian, Zahra Clin Case Rep Case Report Immune thrombocytopenic purpura (ITP) is an autoimmune disease characterized by a low platelets count. In this paper, we present a case of ITP relapse in a 31‐year‐old Iranian woman as a potential complication of the AstraZeneca vaccine. John Wiley and Sons Inc. 2023-09-04 /pmc/articles/PMC10477723/ /pubmed/37675411 http://dx.doi.org/10.1002/ccr3.7872 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Case Report Seyedi, Saba Navid, Shadan Saadatian, Zahra Relapse of immune thrombocytopenia after receiving AstraZeneca coronavirus disease‐2019 vaccine: A case report |
title | Relapse of immune thrombocytopenia after receiving AstraZeneca coronavirus disease‐2019 vaccine: A case report |
title_full | Relapse of immune thrombocytopenia after receiving AstraZeneca coronavirus disease‐2019 vaccine: A case report |
title_fullStr | Relapse of immune thrombocytopenia after receiving AstraZeneca coronavirus disease‐2019 vaccine: A case report |
title_full_unstemmed | Relapse of immune thrombocytopenia after receiving AstraZeneca coronavirus disease‐2019 vaccine: A case report |
title_short | Relapse of immune thrombocytopenia after receiving AstraZeneca coronavirus disease‐2019 vaccine: A case report |
title_sort | relapse of immune thrombocytopenia after receiving astrazeneca coronavirus disease‐2019 vaccine: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477723/ https://www.ncbi.nlm.nih.gov/pubmed/37675411 http://dx.doi.org/10.1002/ccr3.7872 |
work_keys_str_mv | AT seyedisaba relapseofimmunethrombocytopeniaafterreceivingastrazenecacoronavirusdisease2019vaccineacasereport AT navidshadan relapseofimmunethrombocytopeniaafterreceivingastrazenecacoronavirusdisease2019vaccineacasereport AT saadatianzahra relapseofimmunethrombocytopeniaafterreceivingastrazenecacoronavirusdisease2019vaccineacasereport |